Novo Nordisk Aktie
WKN DE: A3EU6F / ISIN: DK0062498333
|
29.10.2025 10:45:00
|
Novo Nordisk Shares Fell 5.6% After President Trump Commented on Future Price Cuts for Weight Loss Drugs. Should Investors Be Worried?
Novo Nordisk (NYSE: NVO) has not had a great year. The company's shares have been southbound due to clinical setbacks and worse-than-expected financial results. The Denmark-based drugmaker continues to encounter some headwinds.Recent comments from President Trump sent the stock down by almost 6% in a single day. Let's discuss what investors should do about these recent developments.Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu :be AG Inhaber-Aktmehr Nachrichten
Analysen zu Novo Nordiskmehr Analysen
| 27.10.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 22.10.25 | Novo Nordisk Neutral | UBS AG | |
| 22.10.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 22.10.25 | Novo Nordisk Outperform | Bernstein Research | |
| 20.10.25 | Novo Nordisk Outperform | Bernstein Research |
Aktien in diesem Artikel
| Novo Nordisk | 44,69 | -0,25% |
|
| Novo Nordisk (spons. ADRs) | 45,00 | 1,35% |
|